Australia TGA ARTG recordSelf-care monitoring web-based application software
Australia TGA ARTG Registered Device · Resmed Pty Ltd · ResMed Corp · Class IIa · Started June 26, 2023
Good Name: Resmed Pty Ltd - Self-care monitoring web-based application software
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- June 26, 2023
- Effective Date
- June 26, 2023
- Name
- Resmed Pty Ltd
- Name
- ResMed Corp
- Country
- United States of America
- Address
- 9001 Spectrum Center Blvd, San Diego, CA, 92123
myAir is a patient engagement software platform for use by patients who are prescribed a compatible ResMed device for the purpose of self-tracking therapy usage data and receiving coaching (educational videos, tips) in a personal home setting. The Personal Therapy Assistant (PTA) feature of myAir is intended for patients who are prescribed a compatible ResMed Air11 platform device to remotely simulate therapy prior to using their device with their prescribed settings. myAir is an optional software accessory to allow patients to acclimate to their therapy device.
Access comprehensive regulatory information for Self-care monitoring web-based application software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Resmed Pty Ltd, manufactured by ResMed Corp in United States of America. The device registration started on June 26, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.